Synapse - Works

Results (115370)

Data-driven harmonization of 2022 WHO and ICC classifications of myelodysplastic syndromes/neoplasms (MDS): A study by the International Consortium for MDS (icMDS)

Meeting Abstract

Lanino, L.; Ball, S.; Bewersdorf, J. P.; Marchetti, M.; Maggioni, G.; Travaglino, E.; Al Ali, N. H.; Fenaux, P.; Platzbecker, U.; Santini, V.; more...
Blood (2023)

Fulltext@MSK | Save

Radiation and busulfan-free hematopoietic stem cell transplantation using briquilimab (JSP191) anti-CD117 antibody-conditioning, transient immunosuppression and TCRαβ (+) T-cell/CD19 (+) B-cell depleted haploidentical grafts in patients with fanconi anemia

Meeting Abstract

Agarwal, R.; Bertaina, A.; Soco, C. F.; Saini, G.; Kunte, N.; Hiroshima, L.; Chan, Y. Y.; Willner, H.; Krampf, M. L.; Nofal, R.; more...
Blood (2023)

Fulltext@MSK | Save

Risk factors and outcomes for hematotoxicity following tisagenlecleucel for pediatric B-acute lymphoblastic leukemia

Meeting Abstract

McNerney, K. O.; Fabrizio, V. A.; Talleur, A. C.; Lim, S. S.; Dreyzin, A.; Baggott, C.; Vatsayan, A.; Rossoff, J.; Prabhu, S.; Pacenta, H. L.; more...
Blood (2023)

Fulltext@MSK | Save

Biological and clinical significance of undetectable circulating tumor cells (CTCs) in patients (pts) with multiple myeloma (MM)

Meeting Abstract

Garcés, J. J.; Termini, R.; Martín-Sánchez, E.; Lasa, M.; Perez, J. J.; Gutierrez, N. C.; Fernández, M.; Calasanz, M. J.; Rosiñol, L.; Garcia, M. T. H.; more...
Blood (2023)

Fulltext@MSK | Save

Post-Hoc analysis of measurable residual disease from BMT-CTN 1506/MORPHO: FLT3-ITD variant allele frequency and survival are highly correlated

Meeting Abstract

Levis, M. J.; Hamadani, M.; Logan, B. R.; Jones, R. J.; Singh, A. K.; Litzow, M. R.; Wingard, J. R.; Papadopoulos, E. B.; Perl, A.; Soiffer, R. J.; more...
Blood (2023)

Fulltext@MSK | Save

DNA methylation-based classification of hairy cell leukemia and splenic B cell lymphoma

Meeting Abstract

Yamaguchi, K.; Abdelbaky, S.; Arons, E.; Cross, M.; Wu, Y. Z.; Weigel, C.; Anghelina, M. I.; Parker, H.; Kibler, A.; Salido, M.; more...
Blood (2023)

Fulltext@MSK | Save

Outcomes of patients with richter transformation without prior chemoimmunotherapy for CLL/SLL: An international multicenter retrospective study

Meeting Abstract

Kittai, A. S.; Huang, Y.; Miller, S.; Allan, J. N.; Bhat, S. A.; Bond, D. A.; Brander, D. M.; Byrd, J. C.; Chavez, J. C.; Chong, E. A.; more...
Blood (2023)

Fulltext@MSK | Save

Pirtobrutinib in post-cBTKi CLL/SLL: ∼30 months follow-up and subgroup analysis with/without prior BCL2i from the phase 1/2 BRUIN study

Meeting Abstract

Woyach, J. A.; Brown, J. R.; Ghia, P.; Roeker, L. E.; Patel, K.; Eyre, T. A.; Munir, T.; Lech-Maranda, E.; Lamanna, N.; Tam, C. S.; more...
Blood (2023)

Fulltext@MSK | Save

Pirtobrutinib in relapsed/refractory (R/R) mantle cell lymphoma (MCL) patients with prior cBTKi: Safety and efficacy including high-risk subgroup analyses from the phase 1/2 BRUIN study

Meeting Abstract

Cohen, J. B.; Shah, N. N.; Jurczak, W.; Zinzani, P. L.; Cheah, C. Y.; Eyre, T. A.; Ujjani, C. S.; Koh, Y.; Kim, W. S.; Nasta, S. D.; more...
Blood (2023)

Fulltext@MSK | Save

Obecabtagene autoleucel (obe-cel, AUTO1) for relapsed/refractory adult B-cell acute lymphoblastic leukemia (R/R B-ALL): Pooled analysis of the ongoing FELIX phase Ib/II study

Meeting Abstract

Roddie, C.; Sandhu, K. S.; Tholouli, E.; Shaughnessy, P.; Barba, P.; Guerreiro, M.; Bishop, M. R.; Yared, J. A.; Ghobadi, A.; Yallop, D.; more...
Blood (2023)

Fulltext@MSK | Save